| Ticker: TXM | 36 Apple Ridge Road | |
| Exchange: American Stock Exchange | Danbury, Connecticut | |
| Industry: Manufacturing | (203) 790-1188 |
| Type of Shares: | Common Shares | Filing Date: | 4/1/96 | |
| U.S. Shares: | 2,500,000 | Offer Date: | 6/27/96 | |
| Non-U.S. Shares: | 0 | Filing Range: | $12.00 - $14.00 | |
| Primary Shares: | 2,500,000 | Offer Price: | $14.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.91 | |
| Offering Amount: | $32,500,000 | Selling: | $0.53 | |
| Expenses: | $700,000 | Reallowance: | $0.10 | |
| Shares Out After: | 25,589,029 | |||
| Spin out parent firm: | ThermoTrex Corporation | |||
| Manager | Tier | Phone |
| Natwest Securities Ltd | Lead Manager | (212) 602-4800 |
| Lehman Brothers Incorporated | Co-manager | (212) 640-6129 |
| Oppenheimer & Company, Inc. | Co-manager | (212) 667-7402 |
| Auditor: Arthur Andersen | |||||
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/94 | 3/30/96 | 4/1/95 | 3/30/96 | ||
| Revenue: | $54.41 | $66.83 | $31.32 | Assets: | $161.30 |
| Net Income: | $1.19 | $3.73 | $0.97 | Liabilities: | $97.86 |
| EPS: | $0.06 | $0.17 | $0.05 | Equity: | $63.43 |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The Company is a worldwide leader in the design, manufacture and marketing of mammography equipment and minimally invasive stereotactic needle biopsy systems used for the detection of breast cancer. A mammography system is a dedicated radiographic system designed specifically to image breast tissue. Stereotactic needle biopsy systems, which use a guided hollow needle to extract a sample of tissues from the breast, offer a cost-effective, less invasive alternative to open surgery for the biopsy of suspicious breast lesions. The Company recently broadened its product base by acquiring Bennett X-Ray Corporation ("Bennett"), a leading producer of specialty and general purpose radiographic systems, including mammography systems. The Company's mammography and stereotactic needle biopsy systems are used by radiologists and physicians in offices, hospitals and dedicated breast-care centers, and its general radiography systems are used by physicians and radiologists, both in office and hospital settings, as well as by veterinarians and chiropractors. The Company sells its systems worldwide principally through a network of independent dealers. In addition, the Company manufactures mammography and radiography systems and components as an original equipment manufacturer for other medical equipment companies. |
| Use of Proceeds |
| The proceeds from the offering will be used for research and development and for general corporate purposes including acquisitions. |
©1996 IPO Data Systems, Inc. - All rights reserved.